¶ SPARC Protein — Secreted Protein Acidic and Rich in Cysteine
| SPARC Protein |
|---|
| Gene | [SPARC](/genes/sparc) |
| UniProt ID | [P09486](https://www.uniprot.org/uniprot/P09486) |
| Molecular Weight | ~43 kDa |
| Subcellular Localization | Extracellular matrix, secreted |
| Protein Family | SPARC family ( matricellular proteins) |
| PDB Structures | [1BM1](https://www.ebi.ac.uk/pdbe/entry/pdb/1bm1), [1SEA](https://www.ebi.ac.uk/pdbe/entry/pdb/1sea) |
SPARC (Secreted Protein Acidic and Rich in Cysteine), also known as osteonectin, is a matricellular protein that modulates cell-matrix interactions and tissue remodeling. In the nervous system, SPARC plays important roles in synaptic function, neural development, and has been implicated in various neurodegenerative diseases.
SPARC is a multifunctional protein with distinct domains:
- N-terminal acidic domain: Binds hydroxyapatite and calcium (EC domain)
- Central Follistatin-like domain (FS): Mediates cell interactions
- C-terminal extracellular calcium-binding domain (EC): Copper-binding motif
- Matricellular signature: Functions outside traditional ECM structural proteins
The protein undergoes post-translational modification including glycosylation and has multiple calcium-binding sites.
SPARC performs essential functions in brain development and function:
- Synaptogenesis: Promotes excitatory synapse formation
- Glial function: Regulates astrocyte and oligodendrocyte behavior
- Myelination: Influences oligodendrocyte maturation
- Blood-brain barrier: Modulates endothelial barrier function
- Neural stem cells: Supports neural progenitor cell proliferation
SPARC is expressed in neurons, astrocytes, and oligodendrocytes throughout development and in adulthood. It is particularly important during periods of active synaptic remodeling.
SPARC is implicated in multiple aspects of AD pathophysiology:
- Amyloid metabolism: Modulates A-beta production and clearance
- Synaptic dysfunction: Loss of SPARC affects excitatory synapses
- Glial reactivity: Alters astrocyte responses to pathology
- Therapeutic potential: SPARC-based approaches for synapse protection
- Modulates dopaminergic neuron survival
- Alters glial responses in the substantia nigra
- May affect alpha-synuclein aggregation
- Critical for oligodendrocyte function and myelination
- Demyelinating lesions show altered SPARC expression
- Potential for remyelination therapies
- Motor neuron expression of SPARC
- Glial contribution to disease progression
- Modulates neuroinflammation
SPARC offers several therapeutic opportunities:
- Recombinant SPARC: For promoting synaptic protection
- SPARC mimetics: Small peptides mimicking SPARC function
- Gene therapy: AAV-mediated SPARC delivery
- Antibody approaches: Targeting SPARC pathways
SPARC interacts with numerous cellular targets:
- Platelet-derived growth factor (PDGF): Modulates PDGF signaling
- Vascular endothelial growth factor (VEGF): Regulates angiogenesis
- Integrins: Cell-matrix adhesion via alphaVbeta3, alpha5beta1
- Collagen types I, III, V: Binds to ECM components
- MMPs: Regulates matrix metalloproteinase activity
- SPARC in synaptic plasticity and memory (2019)
- Matricellular proteins in neurodegeneration (2020)
- SPARC and Alzheimer's disease pathology (2021)
- Oligodendrocyte SPARC in demyelination (2022)
- Therapeutic targeting of SPARC in CNS disorders (2023)